[FATE] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
01-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -10.77%
YoY- -22.28%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 7,558 2,429 1,026 1,026 1,026 1,026 0 -
PBT -58,684 -26,609 -16,782 -10,684 -8,737 -6,886 -6,603 43.87%
Tax 0 910 339 378 37 4 187 -
NP -58,684 -26,609 -16,782 -10,684 -8,737 -6,886 -6,603 43.87%
Tax Rate - - - - - - - -
Total Cost 66,242 29,038 17,808 11,710 9,763 7,912 6,603 46.80%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -776.45 -1,095.47 -1,635.67 -1,041.33 -851.56 -671.15 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.68 -0.40 -0.31 -0.26 -0.27 -0.24 -0.32 13.37%
EPS Diluted -0.68 -0.40 -0.31 -0.26 -0.27 -0.24 -0.32 13.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.